Serono launches new patient-assistance program

MS LifeLines Access Made Simple is a new program launched by EMD Serono to provide access to therapy for patients with relapsing forms of multiple sclerosis. Patients must have been newly prescribed interferon beta-1 (Rebif) or have been restarted following discontinuation for more than 90 days. The program helps patients gain access to therapy as soon as possible following diagnosis by delivering the Rebif treatments along with educational services that are required to optimize long-term therapy success. MS LifeLines program reimbursement experts work to secure insurance coverage with the patient and his or her own insurance company. If coverage cannot be secured through a patient's own insurance company, EMD Serono will cover the cost of therapy for the first year. According to the company, there is no enrollment process for the MS LifeLines Access Made Simple program and eligible patients can be enrolled when they follow the standard procedures already in place for voluntary enrollment in MS LifeLines support services.

To see more Hot off the Press news articles, click here.

To go to the Drug Topics homepage, click here.